| Suppression of the growth and invasion of human head and neck squamous cell carcinomas via regulating STAT3 signaling and the miR-21/β-catenin axis with HJC0152 Y Wang, S Wang, Y Wu, Y Ren, Z Li, X Yao, C Zhang, N Ye, C Jing, ... Molecular cancer therapeutics 16 (4), 578-590, 2017 | 55 | 2017 |
| Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion Corrigendum in/10.3892/ijo. 2023.5528 Y Wang, W Guo, Z Li, Y Wu, C Jing, Y Ren, M Zhao, L Kong, C Zhang, ... International journal of oncology 52 (4), 1149-1164, 2018 | 43 | 2018 |
| Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis D Li, H Wang, Y Ding, Z Zhang, Z Zheng, J Dong, H Kim, X Meng, Q Zhou, ... Cancer letters 424, 97-108, 2018 | 38 | 2018 |
| A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma Z Li, T Zhu, Y Xu, C Wu, J Chen, Y Ren, L Kong, S Sun, W Guo, Y Wang, ... American journal of cancer research 9 (4), 699, 2019 | 24 | 2019 |
| Fibroblast growth factor receptor 1 drives the metastatic progression of prostate cancer E Labanca, J Yang, PDA Shepherd, X Wan, MW Starbuck, LD Guerra, ... European Urology Oncology 5 (2), 164-175, 2022 | 21 | 2022 |
| Preoperative plasma fibrinogen predicts cervical metastasis in patients with stage I/II carcinoma of the tongue P Peng, J Shen, JB Dong, Y Zhang International journal of oral and maxillofacial surgery 43 (4), 393-398, 2014 | 9 | 2014 |
| Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series N Anselmino, E Labanca, PDA Shepherd, J Dong, J Yang, X Song, ... Clinical Cancer Research 30 (10), 2272-2285, 2024 | 7 | 2024 |
| Integrative analysis of the MD anderson prostate cancer patient-derived xenograft series (MDA PCa PDX) N Anselmino, E Labanca, X Song, J Yang, PDA Shepherd, J Dong, ... bioRxiv, 2022.07. 21.500652, 2022 | 2 | 2022 |
| Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents J Xu, H Kim, J Dong, H Chen, J Xu, R Ma, M Zhou, T Wang, Q Shen, ... European journal of medicinal chemistry 234, 114229, 2022 | 2 | 2022 |
| Chemoprevention of breast cancer by targeting glucose metabolism with HJC0152 H Kim, J Dong, L Wang, J Xu, D Zhang, R Yan, H Zou, H Chen, X Liu, ... Cancer Research 79 (13_Supplement), 5066-5066, 2019 | 1 | 2019 |
| Anti-sense miRNA-21 oligonucleotide inhibits Tb 3.1 human tongue squamous cell carcinoma growth in vitro YJ Tao, Y Ren, JB Dong, L Zhang, JP Cheng, X Zhou Zhonghua kou Qiang yi xue za zhi= Zhonghua Kouqiang Yixue Zazhi= Chinese …, 2011 | 1 | 2011 |
| [Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion Y Wang, W Guo, Z Li, Y Wu, C Jing, Y Ren, M Zhao, L Kong, C Zhang, ... international journal of oncology 63 (1), 1-3, 2023 | | 2023 |
| Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion Y Wang, W Guo, Z Li, Y Wu, C Jing, Y Ren, M Zhao, L Kong, C Zhang, ... international journal of oncology 63 (1), 80, 2023 | | 2023 |
| Candidate measures of lineage plasticity in aggressive phenotypes of prostate cancer S Logotheti, H Vundavilli, E Papadaki, Y Zhao, MR Estecio, ... Cancer Research 83 (7_Supplement), 142-142, 2023 | | 2023 |
| Defining lineage plasticity in androgen indifferent prostate cancer S Logotheti, H Vundavilli, M Estecio, R Soundararajan, P Shepherd, ... VIRCHOWS ARCHIV 481 (SUPPL 1), S19-S19, 2022 | | 2022 |
| Abstract P2-06-13: A novel small molecule JMX0293 inhibits the growth of triple-negative breast cancer via suppressing STAT3 and inducing apoptosis J Dong, J Xu, H Kim, J Zhou, Q Shen Cancer Research 79 (4_Supplement), P2-06-13-P2-06-13, 2019 | | 2019 |
| Abstract P5-21-19: Suppression of breast carcinogenesis and metastasis by targeting glucose metabolism with HJC0152 J Dong, H Kim, J Xu, D Li, Z Zhang, Z Zheng, N Ye, H Chen, J Zhou, ... Cancer Research 78 (4_Supplement), P5-21-19-P5-21-19, 2018 | | 2018 |
| Abstract P3-06-09: Discovery of novel oridonin-derivatives for the treatment of metastatic breast cancer D Li, Z Zhang, Y Ding, Z Zheng, J Dong, H Kim, J Xu, H Chen, J Zhou, ... Cancer Research 78 (4_Supplement), P3-06-09-P3-06-09, 2018 | | 2018 |
| Discovery of novel oridonin-derivatives for the treatment of metastatic breast cancer D Li, Z Zhang, Y Ding, Z Zheng, J Dong, H Kim, J Xu, H Chen, J Zhou, ... CANCER RESEARCH 78 (4), 2018 | | 2018 |
| Abstract LB-299: Glucose metabolism modulator HJC0152 differentially regulates glycolytic enzymes to suppress breast carcinogenesis J Dong, D Li, H Kim, H Wang, Z Zheng, Z Zhang, N Ye, H Chen, J Zhou, ... Cancer Research 77 (13_Supplement), LB-299-LB-299, 2017 | | 2017 |
